Revvity Inc. $RVTY Shares Sold by Koshinski Asset Management Inc.

Koshinski Asset Management Inc. lessened its stake in Revvity Inc. (NYSE:RVTY) by 1.9% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,728 shares of the company’s stock after selling 129 shares during the quarter. Koshinski Asset Management Inc.’s holdings in Revvity were worth $651,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in RVTY. UMB Bank n.a. boosted its holdings in shares of Revvity by 138.8% in the 2nd quarter. UMB Bank n.a. now owns 406 shares of the company’s stock valued at $39,000 after purchasing an additional 236 shares during the last quarter. New Age Alpha Advisors LLC acquired a new position in shares of Revvity in the 1st quarter valued at $44,000. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Revvity by 25.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company’s stock valued at $73,000 after purchasing an additional 140 shares during the last quarter. Cary Street Partners Investment Advisory LLC acquired a new position in shares of Revvity in the 1st quarter valued at $75,000. Finally, Farther Finance Advisors LLC boosted its holdings in shares of Revvity by 21.2% in the 1st quarter. Farther Finance Advisors LLC now owns 796 shares of the company’s stock valued at $83,000 after purchasing an additional 139 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Stock Performance

Shares of RVTY stock opened at $93.60 on Monday. Revvity Inc. has a 12 month low of $81.36 and a 12 month high of $129.50. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. The firm has a market capitalization of $10.86 billion, a P/E ratio of 39.66, a P/E/G ratio of 3.12 and a beta of 0.98. The company’s fifty day moving average price is $88.59 and its two-hundred day moving average price is $92.30.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Monday, July 28th. The company reported $1.18 EPS for the quarter, topping analysts’ consensus estimates of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm had revenue of $720.28 million for the quarter, compared to analyst estimates of $711.26 million. During the same quarter in the previous year, the business posted $1.22 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. On average, research analysts anticipate that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 7th. Shareholders of record on Friday, October 17th will be issued a $0.07 dividend. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity’s payout ratio is currently 11.86%.

Analysts Set New Price Targets

RVTY has been the topic of several recent research reports. Evercore ISI reduced their target price on shares of Revvity from $108.00 to $106.00 and set an “outperform” rating on the stock in a report on Tuesday, October 7th. Guggenheim initiated coverage on shares of Revvity in a report on Wednesday. They set a “neutral” rating on the stock. Stifel Nicolaus reduced their target price on shares of Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a report on Tuesday, July 29th. Raymond James Financial restated an “outperform” rating and set a $115.00 target price (down previously from $120.00) on shares of Revvity in a report on Tuesday, July 29th. Finally, Bank of America reduced their target price on shares of Revvity from $110.00 to $99.00 and set a “buy” rating on the stock in a report on Monday, September 22nd. Nine investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $116.62.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.